Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study

Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study

Abstract Background The programmed cell death-1 (PD-1)/programmed cell death-ligand 1 (PD-L1) pathway inhibits the activation of T cells and plays a crucial role in the negative regulation of cellular and humoral immune responses. Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid mal...

Full description

Bibliographic Details
Main Authors: Li-Yang Hu, Xiao-Lu Xu, Hui-Lan Rao, Jie Chen, Ren-Chun Lai, Hui-Qiang Huang, Wen-Qi Jiang, Tong-Yu Lin, Zhong-Jun Xia, Qing-Qing Cai
Format: Article
Language:English
Published: BMC 2017-12-01
Series:Chinese Journal of Cancer
Subjects:
Programmed cell death-ligand 1 (PD-L1)
Diffuse large B-cell lymphoma
C-Myc
Prognosis
Online Access:http://link.springer.com/article/10.1186/s40880-017-0262-z

Internet

http://link.springer.com/article/10.1186/s40880-017-0262-z

Similar Items